162 related articles for article (PubMed ID: 454514)
1. The results of animal studies with ciprofibrate, a new orally effective hypolipidemic drug.
Arnold A; McAuliff JP; Powers LG; Phillips DK; Beyler AL
Atherosclerosis; 1979 Feb; 32(2):155-63. PubMed ID: 454514
[TBL] [Abstract][Full Text] [Related]
2. Metabolic effects of a new hypolipidemic agent, ciprofibrate.
Arnold A; McAuliff MP; Beyler AL
J Pharm Sci; 1979 Dec; 68(12):1557-8. PubMed ID: 529054
[TBL] [Abstract][Full Text] [Related]
3. Effects of ciprofibrate and fenofibrate on liver lipids and lipoprotein synthesis in normo- and hyperlipidemic rats.
Petit D; Bonnefis MT; Rey C; Infante R
Atherosclerosis; 1988 Dec; 74(3):215-25. PubMed ID: 3240333
[TBL] [Abstract][Full Text] [Related]
4. Treatment of hypertriglyceridemia with tibric acid and clofibrate. Cross-over studies, effects on lipoproteins and absence of post-drug rebound.
Smith FR; Noble RP; Goodman DS
Atherosclerosis; 1978 Mar; 29(3):345-54. PubMed ID: 666884
[No Abstract] [Full Text] [Related]
5. Blood levels, tissue distribution and the duration of action in rats of ciprofibrate, a new hypolipidemic agent.
Edelson J; Benziger DP; Arnold A; Beyler AL
Atherosclerosis; 1979 Jul; 33(3):351-7. PubMed ID: 486226
[TBL] [Abstract][Full Text] [Related]
6. [The mechanisms of action of etophylline-clofibrate in hyperlipidemia].
Păduraru I; Nechifor M; Dănilă G; Jercă L; Filip M; Iacobovici A; Teslaru E; Filip C; Saramet A
Rev Med Chir Soc Med Nat Iasi; 1993; 97(1):445-9. PubMed ID: 8153471
[No Abstract] [Full Text] [Related]
7. [Overviews of fibrate].
Tada N
Nihon Rinsho; 2001 Mar; 59 Suppl 3():609-17. PubMed ID: 11347141
[No Abstract] [Full Text] [Related]
8. Experimental hyper-beta-lipoproteinemia and its amelioration by a novel hypolipidemic agent.
Kobayakawa T; Osuga K; Yasuda H
Atherosclerosis; 1978 Jul; 30(3):219-25. PubMed ID: 209804
[TBL] [Abstract][Full Text] [Related]
9. A comparison of fenofibrate and clofibrate hypolipidemic effects.
Daubresse JC
Acta Clin Belg; 1980; 35(4):227-32. PubMed ID: 7015771
[No Abstract] [Full Text] [Related]
10. Ciprofibrate increases plasma concentration of platelet-derived growth factor AB in patients with advanced atherosclerosis and hyperlipidemia independently of its hypolipidemic effects.
Gajdos M; Mongiellová V; Huttová D; Cibulová L; Krivosíková Z; Spustová V; Dzúrik R
J Cardiovasc Pharmacol; 2001 Nov; 38(5):651-6. PubMed ID: 11602811
[TBL] [Abstract][Full Text] [Related]
11. Dose-response study of the effect of ciprofibrate on serum lipoprotein concentrations in hyperlipoproteinaemia.
Olsson AG; Orö L
Atherosclerosis; 1982 Apr; 42(2-3):229-43. PubMed ID: 6951582
[TBL] [Abstract][Full Text] [Related]
12. Ciprofibrate and lipid profile.
Chandler HA; Batchelor AJ
Lancet; 1994 Jul; 344(8915):128-9. PubMed ID: 7912363
[No Abstract] [Full Text] [Related]
13. The antilipemic effectiveness of aluminium clofibrate on hyperlipidemic patients with or without diabetes mellitus.
Lam HC; Li SH; Wang JT; Tang KT; Ho LT
Zhonghua Yi Xue Za Zhi (Taipei); 1987 Nov; 40(5):463-70. PubMed ID: 3332236
[No Abstract] [Full Text] [Related]
14. Hypolipidemic effect of a new aryloxy compound, S-8527, in experimental animals.
Suzuki K; Aono S; Nakatani H
Jpn J Pharmacol; 1974 Jun; 24(3):407-14. PubMed ID: 4449146
[No Abstract] [Full Text] [Related]
15. Editorial: Lipid-lowering drugs after myocardial infarction.
Lancet; 1975 Mar; 1(7905):501-2. PubMed ID: 46964
[No Abstract] [Full Text] [Related]
16. Influence of gemfibrozil and clofibrate on metabolism of cholesterol and plasma triglycerides in man.
Kesäniemi YA; Grundy SM
JAMA; 1984 May; 251(17):2241-6. PubMed ID: 6368883
[TBL] [Abstract][Full Text] [Related]
17. A comparative study of a new drug MK 185 with clofibrate in the treatment of hyperlipidaemias.
Jepson EM; Small E; Grayson MF; Bance G; Billimoria JD
Atherosclerosis; 1972; 16(1):9-14. PubMed ID: 4341723
[No Abstract] [Full Text] [Related]
18. Novel lipid-lowering properties of Vaccinium myrtillus L. leaves, a traditional antidiabetic treatment, in several models of rat dyslipidaemia: a comparison with ciprofibrate.
Cignarella A; Nastasi M; Cavalli E; Puglisi L
Thromb Res; 1996 Dec; 84(5):311-22. PubMed ID: 8948058
[TBL] [Abstract][Full Text] [Related]
19. Hypolipidemic effects of Teucrium polium in rats.
Rasekh HR; Khoshnood-Mansourkhani MJ; Kamalinejad M
Fitoterapia; 2001 Dec; 72(8):937-9. PubMed ID: 11731122
[TBL] [Abstract][Full Text] [Related]
20. Comparative study of several hypolipidemic agents related to clofibrate.
Beaumont V; Buxtorf JC; Jacotot B; Beaumont JL
Atherosclerosis; 1974; 20(2):141-53. PubMed ID: 4369878
[No Abstract] [Full Text] [Related]
[Next] [New Search]
